The biggest story this week in the marijuana world was the inclusion of the Rohrabacher-Blumenauer language (Section 537) in the omnibus spending package to prevent the Department of Justice from interfering with lawful state-regulated medical marijuana consumers and businesses.
In a signing statement by President Trump, expressed that he “will treat this provision consistently with my constitutional responsibility to take care that the laws be faithfully executed” when it comes to Section 537. The lack of clarity is disturbing and casts doubt on whether his administration and Attorney General Jeff Sessions will honor the enforcement restrictions. In the past, the courts have upheld this tactic of Congress legislating through the appropriations process, however it will ultimately take a bill to end this tension between the federal and state laws, not just temporary spending riders.
Also this week, Representative Jared Polis held an event in the foyer of the Rayburn House Office Building solely focused on marijuana policy. Speakers included Boulder County D.A. Stan Garnett and former Colorado NORML Executive Director Rachel Gillette.
For the whole morning, the halls of Rayburn echoed with the words of cannabis reformers declaring the need for sensible policies on marijuana ranging from the need for 280E tax reform to an end to the delusional thought that a southern boarder wall will stop the drug trade.
At the state level, this has been a very active week for marijuana reformers as additional states near the end of their legislative calendars. Progress has been made from Texas moving forward to establish a medical marijuana program to Vermont inching closer towards outright legalization. Yet with the end of the Florida legislative session, the House and Senate were unable to come to a compromise as how to implement Amendment 2 and now the rule making process will be left up to the Florida Department of Health.
Following are the bills from around the country that we’ve tracked this week and as always, check http://norml.org/act for legislation pending in your state.
Don’t forget to sign up for our email list and we will keep you posted as these bills and more move through your home state legislature and at the federal level.
Thanks for all you do and keep fighting,
Join The Caucus: With public support for reforming marijuana laws at an all time high, Reps. Earl Blumenauer (D-OR), Dana Rohrabacher (R-CA), Jared Polis (D-CO), and Don Young (R-AK) earlier this year formed the Congressional Cannabis Caucus to develop and promote sensible cannabis policy reform and work to ease the tension between federal and state cannabis laws.
After nearly a decade of frustration, 2017 may finally be the year that New Hampshire voters successfully see marijuana possession decriminalized.
HB 640, sponsored by 6 Republicans and 6 Democrats, will amend criminal penalties for marijuana possession is pending in the House, where lawmakers have overwhelmingly supported such efforts for eight years in a row. However, legislators this year are hopeful that, for the first time, they also have sufficient votes to also clear the Senate.
Update: Governor Chris Sununu has reiterated his support for decriminalizing marijuana.
Legislation to authorize the possession, production, and distribution of medical marijuana and marijuana-infused products to qualified patients. Patients would receive cannabis through a network of private dispensaries and operators, similar to pharmacies, regulated under “strict guidelines” by the Texas Department of Public Safety.
Update: HB 2107 had a hearing on May 2 and after powerful targeted testimony, the number of cosponsors for the bill jumped from 5 to 75. Later in the week, the Texas House of Representatives Committee on Public Health approved HR 2107 on May 5 by a vote of 7-2. The bill will now be considered by the Calendars Committee to determine the date of the full House vote.
Legislation is pending, H.170, to eliminate civil and criminal penalties specific to the possession and cultivation of personal use quantities of marijuana by adults.
Update: The Senate has passed on May 5 an unrelated bill (S. 22) to include the provisions of H. 170. It maintains House approved language eliminating penalties for the possession and cultivation of personal use amounts of marijuana by July 2018, but also creates a new Marijuana Regulation Commission, to draft legislation by November 1, 2017 that “establishes a comprehensive regulatory and revenue system for an adult-use marijuana market that, when compared to the current illegal marijuana market, increases public safety and reduces harm to public health.” The commission’s bill would be ready for a vote by January 2018.
Additional Actions to Take
State officials in Colorado are considering legislation, SB 192, to protect the state’s adult use marijuana industry in case of a potential federal crackdown.
The bill would permit adult use growers and sellers to instantly reclassify their recreational marijuana inventory as medical marijuana “based on a business need due to a change in local, state, or federal law or enforcement policy.” In recent weeks, officials from the Trump administration have indicated that they may consider taking action against recreational marijuana providers, but that they will not likely move against state-licensed medical marijuana providers.
Update: House members approved SB 192 on May 3 by a vote of 58 to 5. Because of House amendments, the bill returns to the Senate, which must either re-approve the measure or seek reconciliation.
SB 35, introduced by Sen. Yvonne Colomb, provides explicit exemptions from arrest and prosecution for persons lawfully in possession of medical marijuana.
Presently, state regulators are finalizing rules and regulations governing its nascent medical cannabis program, which seeks to permit the production, dispensing, and use of non-herbal preparations of cannabis for qualified patients. Passage of SB 36 amends various criminal statutes to assure that those involved in the program are not inadvertently subject to criminal liability.
Specifically, it provides immunity from arrest for those enrolled in the program who engage in activities related to the purchase or transportation of medical marijuana related products or paraphernalia. It provides further legal protections for pharmacies, producers, and testing laboratories engaged in medical cannabis related activities.
Update: Members of the Senate Judiciary Committee voted without opposition to move SB 35 to the Senate floor.
Legislation is pending to expedite the retail sale of marijuana products to those over the age of 21.
LD 1448 and LD 1491 would permit licensed medical cannabis dispensaries the opportunity to “sell limited marijuana retail products to a person who is 21 years of age or older.”
A majority of voters in November approved an initiated measure to permit the possession, production, and retail sale of marijuana and marijuana-infused products. However, emergency legislation signed into law in January delays the implementation of regulations overseeing the commercial production and retail sale of marijuana until at least February 1, 2018.
Passage of these measures would allow dispensaries to engage in marijuana sales ahead of this date.
Multiple bills are pending before lawmakers to expand the pool of patients eligible to qualify for medical marijuana therapy.
In particular, these measures would permit patients with conditions like chronic pain and post-traumatic stress to obtain legal access to marijuana.
Update: Members of the Senate Health and Human Services Committee on May 4 passed HB 160 out of Committee.
Legislation is moving forward, A. 7006, to allow patients with post-traumatic stress eligible for medical cannabis therapy.
New York is one of the only states with a medical marijuana program that does not allow patients with PTSD access to medical cannabis.
Update: The New York Assembly passed A 7006 on May 2. The bill now awaits action by the Senate. Governor Andrew Cuomo says that he is open to expanding the state’s medical cannabis program to include patients with PTSD.
If approved, SB 16 would permit physicians for the first time to recommend medical marijuana to patients with post-traumatic stress, Crohn’s disease, or Parkinson’s disease. The measure also allows physicians to immediately issue medical cannabis recommendations for patients suffering from cancer, a terminal illness, or under hospice care supervision.
Update: Members of the House gave preliminary approval SB 16 on May 1. Once a final vote is recorded, the measure will be transmitted to the Governor’s office.